International Isotopes Past Earnings Performance
Past criteria checks 0/6
International Isotopes's earnings have been declining at an average annual rate of -7.5%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 8.2% per year.
Key information
-7.5%
Earnings growth rate
-4.0%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | 8.2% |
| Return on equity | -8.6% |
| Net Margin | -2.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How International Isotopes makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 13 | 0 | 8 | 1 |
| 30 Jun 24 | 12 | -1 | 8 | 1 |
| 31 Mar 24 | 12 | -1 | 8 | 1 |
| 31 Dec 23 | 12 | -1 | 8 | 1 |
| 30 Sep 23 | 12 | -1 | 7 | 0 |
| 30 Jun 23 | 12 | -1 | 7 | 1 |
| 31 Mar 23 | 11 | -1 | 7 | 0 |
| 31 Dec 22 | 11 | 0 | 7 | 1 |
| 30 Sep 22 | 10 | 0 | 7 | 1 |
| 30 Jun 22 | 10 | 1 | 7 | 0 |
| 31 Mar 22 | 10 | 1 | 6 | 0 |
| 31 Dec 21 | 10 | -1 | 6 | 0 |
| 30 Sep 21 | 9 | 1 | 6 | 0 |
| 30 Jun 21 | 10 | 2 | 6 | 0 |
| 31 Mar 21 | 9 | 2 | 6 | 0 |
| 31 Dec 20 | 9 | 2 | 6 | 0 |
| 30 Sep 20 | 9 | 0 | 5 | 0 |
| 30 Jun 20 | 9 | -1 | 5 | 0 |
| 31 Mar 20 | 9 | -2 | 5 | 0 |
| 31 Dec 19 | 9 | -2 | 5 | 0 |
| 30 Sep 19 | 9 | -1 | 5 | 0 |
| 30 Jun 19 | 10 | -2 | 5 | 0 |
| 31 Mar 19 | 10 | -1 | 5 | 0 |
| 31 Dec 18 | 10 | -1 | 5 | 0 |
| 30 Sep 18 | 10 | -1 | 4 | 0 |
| 30 Jun 18 | 9 | -3 | 5 | 0 |
| 31 Mar 18 | 8 | -3 | 5 | 0 |
| 31 Dec 17 | 7 | -4 | 5 | 0 |
| 30 Sep 17 | 7 | -3 | 5 | 0 |
| 30 Jun 17 | 7 | -2 | 4 | 0 |
| 31 Mar 17 | 7 | -2 | 4 | 0 |
| 31 Dec 16 | 7 | -2 | 4 | 1 |
| 30 Sep 16 | 7 | -2 | 4 | 1 |
| 30 Jun 16 | 7 | -2 | 4 | 1 |
| 31 Mar 16 | 7 | -2 | 3 | 1 |
| 31 Dec 15 | 7 | -2 | 3 | 1 |
| 30 Sep 15 | 7 | -2 | 3 | 1 |
| 30 Jun 15 | 7 | -1 | 3 | 0 |
| 31 Mar 15 | 8 | -1 | 3 | 0 |
| 31 Dec 14 | 8 | -2 | 3 | 0 |
| 30 Sep 14 | 7 | -2 | 4 | 1 |
| 30 Jun 14 | 7 | -2 | 4 | 0 |
| 31 Mar 14 | 7 | -2 | 4 | 1 |
| 31 Dec 13 | 7 | -2 | 4 | 1 |
Quality Earnings: INIS is currently unprofitable.
Growing Profit Margin: INIS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INIS is unprofitable, and losses have increased over the past 5 years at a rate of 7.5% per year.
Accelerating Growth: Unable to compare INIS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: INIS is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.7%).
Return on Equity
High ROE: INIS has a negative Return on Equity (-8.58%), as it is currently unprofitable.